The implication of IGF/IGF-1R axis in SS development and management was discussed in a study demonstrating that SS18–SSX1 or SS18–SSX2 fusion genes up-regulate insulin-like growth factor-2 (IGF-2) through epigenetic mechanisms [29]. The gene discussed is SSX2; the disease is synovial sarcoma.